Korro Bio, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 36 rows, 36 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-10-07: Reporting owner Alexandria Venture Investments, LLC; Form 4; Security Series A Convertible Preferred Stock; Transaction C Conversion of derivative security.
- 2019-10-07: Reporting owner Alexandria Venture Investments, LLC; Form 4; Security Series B Convertible Preferred Stock; Transaction C Conversion of derivative security.
- 2019-10-07: Reporting owner COHEN MARC A; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2019-10-07: Reporting owner COHEN MARC A; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
KRRO insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-10-07 | Alexandria Venture Investments, LLC 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −4,161,974 0 owned after | no price filed | $700.00 | 2019-10-09 |
| 2019-10-07 | Alexandria Venture Investments, LLC 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,278,345 0 owned after | no price filed | $700.00 | 2019-10-09 |
| 2019-10-07 | COHEN MARC A Director | 4 | Series A Preferred Stock Derivative · Indirect · The Marc Andrew Cohen Revocable Trust | C Conversion of derivative security | −2,292,235 0 owned after | no price filed | $700.00 | 2019-10-08 |
| 2019-10-07 | COHEN MARC A Director | 4 | Series B Preferred Stock Derivative · Indirect · The Marc Andrew Cohen Revocable Trust | C Conversion of derivative security | −543,219 0 owned after | no price filed | $700.00 | 2019-10-08 |
| 2019-10-07 | COHEN MARC A Director | 4 | Series C Preferred Stock Derivative · Indirect · The Marc Andrew Cohen Revocable Trust | C Conversion of derivative security | −163,388 0 owned after | no price filed | $700.00 | 2019-10-08 |
| 2019-10-07 | Mitrano Richard J. Officer (VP Finance & Operations) | 4 | Series B Preferred Stock Derivative · Indirect · The Carey/Mitrano Family Trust | C Conversion of derivative security | −27,160 0 owned after | no price filed | $700.00 | 2019-10-08 |
| 2019-10-07 | Lucchino David L. Director, Officer (President and CEO) | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −43,989 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | Lucchino David L. Director, Officer (President and CEO) | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −27,161 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | BARBERICH TIMOTHY J Director | 4 | Series A Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | +506,278 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | BARBERICH TIMOTHY J Director | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | +543,219 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | BARBERICH TIMOTHY J Director | 4 | Series C Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | +63,698 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | Loose Christopher R. Officer (Chief Scientific Officer) | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −45,182 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | MARCUS JOEL S Director | 4 | Series A Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −1,534,513 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | MARCUS JOEL S Director | 4 | Series B Preferred Stock Derivative · Direct · (m) | C Conversion of derivative security | −839,816 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | MARCUS JOEL S Director | 4 | Series A Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −4,161,974 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | MARCUS JOEL S Director | 4 | Series B Preferred Stock Derivative · Indirect · (m) | C Conversion of derivative security | −2,278,345 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | Deerfield Mgmt L.P. | DEERFIELD PARTNERS, L.P. | Deerfield Special Situations Fund, L.P. | Deerfield Private Design Fund IV, L.P. | Deerfield Mgmt IV, L.P. | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Flynn James E | | | | | | | 4 | Series C Preferred Stock Derivative · Indirect · Through Deerfield Private Design Fund IV, L.P. | C Conversion of derivative security | −3,184,948 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-07 | Deerfield Mgmt L.P. | DEERFIELD PARTNERS, L.P. | Deerfield Special Situations Fund, L.P. | Deerfield Private Design Fund IV, L.P. | Deerfield Mgmt IV, L.P. | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Flynn James E | | | | | | | 4 | Series C Preferred Stock Derivative · Indirect · Through Deerfield Special Situations Fund, L.P. | C Conversion of derivative security | −3,184,948 0 owned after | no price filed | $700.00 | 2019-10-07 |
| 2019-10-02 holding as of filing | Alexandria Venture Investments, LLC 10% Owner | 3 | Series A Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | Alexandria Venture Investments, LLC 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Direct | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | MARCUS JOEL S Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | MARCUS JOEL S Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | MARCUS JOEL S Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | MARCUS JOEL S Director, 10% Owner | 3 | Series B Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | Loose Christopher R. Officer (Chief Scientific Officer) | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | Mitrano Richard J. Officer (VP Finance & Operations) | 3 | Series B Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | BARBERICH TIMOTHY J Director | 3 | Series A Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | BARBERICH TIMOTHY J Director | 3 | Series B Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | BARBERICH TIMOTHY J Director | 3 | Series C Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | Lucchino David L. Director, Officer (President and CEO) | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | Lucchino David L. Director, Officer (President and CEO) | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | COHEN MARC A Director | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | COHEN MARC A Director | 3 | Series B Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | COHEN MARC A Director | 3 | Series C Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | Deerfield Special Situations Fund, L.P. | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Deerfield Private Design Fund IV, L.P. | Deerfield Mgmt L.P. | Flynn James E | Deerfield Mgmt IV, L.P. | | | | | | 3 | Series C Preferred Stock Derivative · Indirect · Through Deerfield Private Design Fund IV, L.P. | Holding | no price filed | 2019-10-02 | ||
| 2019-10-02 holding as of filing | Deerfield Special Situations Fund, L.P. | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Deerfield Private Design Fund IV, L.P. | Deerfield Mgmt L.P. | Flynn James E | Deerfield Mgmt IV, L.P. | | | | | | 3 | Series C Preferred Stock Derivative · Indirect · Through Deerfield Special Situations Fund, L.P. | Holding | no price filed | 2019-10-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |